Teleflex (TFX) Cash from Investing Activities (2009 - 2026)
Teleflex (TFX) reported Cash from Investing Activities of -$74.8 million for Q1 2026, down 226.36% on a YoY basis from $59.2 million in Q1 2025, and down 629.3% quarter-over-quarter from $14.1 million in Q4 2025.
Teleflex (TFX) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Teleflex has reported Cash from Investing Activities for 18 years, with the latest figure at -$74.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 226.36% year-over-year to -$74.8 million; the trailing twelve-month figure through Mar 2026 stood at -$864.5 million (down 1306.44% YoY), and the FY2025 full-year result was -$812.7 million, down 1182.58% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$74.8 million, down from $14.1 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $85.0 million in Q4 2023, with the low at -$767.5 million in Q3 2025.
- Historically, Cash from Investing Activities has averaged -$69.6 million across 5 years, with a median of -$22.9 million in 2025.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 142.02% — and 2025, when it slumped 3515.18%.
- Teleflex's Cash from Investing Activities stood at -$202.2 million in 2022, then soared by 142.02% to $85.0 million in 2023, then tumbled by 84.81% to $12.9 million in 2024, then advanced by 9.45% to $14.1 million in 2025, then sank by 629.3% to -$74.8 million in 2026.
- The last three Cash from Investing Activities figures came in at -$74.8 million (Q1 2026), $14.1 million (Q4 2025), and -$767.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Teleflex | 5.67 Bn | 5.36 Bn | 307.43 Mn | -74.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.79 Mn |
| Mar 31, 2026 | -74.79 Mn |
| Dec 31, 2025 | 14.13 Mn |
| Dec 31, 2025 | 14.13 Mn |
| Sep 28, 2025 | -767.50 Mn |
| Sep 28, 2025 | -767.50 Mn |
| Jun 29, 2025 | -36.37 Mn |
| Jun 29, 2025 | -36.37 Mn |
| Mar 30, 2025 | -22.92 Mn |
| Mar 30, 2025 | -22.92 Mn |
| Dec 31, 2024 | 12.91 Mn |
| Dec 31, 2024 | 12.91 Mn |
| Sep 29, 2024 | -21.23 Mn |
| Sep 29, 2024 | -21.23 Mn |
| Jun 30, 2024 | -30.23 Mn |
| Jun 30, 2024 | -30.23 Mn |
| Mar 31, 2024 | -24.81 Mn |
| Mar 31, 2024 | -24.81 Mn |
| Dec 31, 2023 | 84.96 Mn |
| Dec 31, 2023 | 84.96 Mn |